President Donald Trump announced Wednesday that he is nominating Dr. Heidi Overton, a White House health policy adviser and physician, to serve as the next commissioner of the Food and Drug Administration (FDA), putting a key architect of the administration's health agenda in charge of one of the nation's most powerful health agencies. The nomination comes at a time when vaccine policy has become one of the most contentious issues inside the Trump administration, with Overton at times viewed differently from Health and Human Services Secretary Robert F.
Kennedy Jr., who spent decades questioning vaccine safety and became one of the country's most prominent vaccine skeptics. If confirmed by the Senate, Overton would inherit an agency that has faced months of upheaval after the departure of former FDA Commissioner Marty Makary and would oversee vaccine approvals, drug regulation, food safety and public health policy. Overton's nomination puts a physician with a traditional medical and public health background at the helm of an agency increasingly caught between competing forces inside the administration.
Kennedy has championed sweeping changes to federal vaccine policy and has repeatedly questioned vaccine safety, while many public health officials continue to defend long-standing immunization programs. The FDA commissioner plays a central role in decisions involving vaccine approvals, labeling, clinical trials and public health guidance. As a result, Overton's views on immunization are likely to face intense scrutiny during Senate confirmation hearings, particularly after the administration's recent efforts to reshape childhood vaccine recommendations.
Overton is a physician and public health specialist who currently serves as deputy director of the White House Domestic Policy Council. She earned a medical degree from the University of New Mexico, completed surgical training at Johns Hopkins and later received a Ph.D. in clinical investigation. She is board-certified in public health and preventive medicine.
Before joining Trump's second administration, Overton worked at the conservative America First Policy Institute, where she led health policy initiatives. She also served as a White House fellow during Trump's first term and has been closely involved in health policy decisions across the administration. Trump praised Overton as a "rockstar" who had worked alongside Kennedy and Centers for Medicare and Medicaid Services Administrator Mehmet Oz on what he called the administration's "most transformative" health agenda, adding that Kennedy had described her as "always right." Although Overton has worked on several Trump administration health initiatives involving vaccines, she has generally been viewed as more aligned with mainstream medical institutions than Kennedy.
As a White House health adviser, she was present when Trump signed a recent executive order directing federal agencies to pursue changes to childhood vaccination schedules, including separating some routine childhood immunizations into different visits. Her role in vaccine policy has placed her at the center of debates over how far the administration should go in altering existing immunization recommendations. Reports have suggested she has sometimes pushed back against elements of Kennedy's Make America Healthy Again (MAHA) movement, creating friction with some activists who favor more aggressive changes to federal vaccine policy.
Extract — continue reading at the source.
